1066 - PSYCHOSOMATIC IN ONCOLOGIC AND CARDIAC DISEASE STUDY: PSYCHOSOCIAL FACTORS AND SHORT-TERM ONTOPSYCHOLOGICAL PSYCHOTHERAPY EARLY INTERVENTION

Session: D08S0022b - Interventions in Health Psychology 2
AUTHORS:
De Angelis Rosanna (International Ontopsychology Association ~ Rome ~ Italy) , Palumbo Gabriella (International Ontopsychology Association ~ Rome ~ Italy) , Roncella Adriana (International Ontopsychology Association ~ Rome ~ Italy) , Mammì Laudonia (San Filippo Neri hospital ~ Rome ~ Italy) , Pasceri Vincenzo (San Filippo Neri hospital ~ Rome ~ Italy) , Pristipino Christian (San Filippo Neri hospital ~ Rome ~ Italy) , Mirri Maria Alessandra (San Filippo Neri hospital ~ Rome ~ Italy) , Corbosiero Angela (San Filippo Neri hospital ~ Rome ~ Italy) , Caporali Fabrizio (San Filippo Neri hospital ~ Rome ~ Italy) , Di Fusco Stefania Angela (San Filippo Neri hospital ~ Rome ~ Italy) , Allan Robert (New York-Presbyterian Hospital ~ New York ~ United States of America) , Colivicchi Furio (San Filippo Neri hospital ~ Rome ~ Italy) , Ciabattoni Antonella (San Filippo Neri hospital ~ Rome ~ Italy) , Ducci Giuseppe (San Filippo Neri hospital ~ Rome ~ Italy) , Speciale Giulio (San Filippo Neri hospital ~ Rome ~ Italy)
Abstract text:
Psychosocial and other modifiable factors influence the development and course of non-communicable diseases (NCDs). Addressing these factors may improve outcomes.
PSYCHONIC (Psychosomatic Medicine in Oncologic and Cardiac Disease; NCT03437642) is an ongoing retrospective-prospective observational study. Its aims are to: (1) characterise psychological profiles in patients with acute myocardial infarction (AMI), Takotsubo syndrome (TTS), and non-metastatic breast cancer (BC), and in age- and sex-matched healthy subjects; (2) examine associations between psychological characteristics and clinical outcomes; and (3) evaluate the effect of short-term ontopsychological psychotherapy (STP) on NCD severity in real-world practice.
Assessments include psychometric and quality-of-life instruments, a body-perception questionnaire, a dream questionnaire, and the Six Drawing Test (6DT). Baseline and follow-up evaluations are planned. Medical endpoints (e.g., recurrent AMI and BC relapse) are also collected.
Patients receiving STP will also receive guideline-based standard care for their condition.
Recruitment began in 2017, paused during the COVID-19 pandemic, and resumed in June 2023. We aim to enrol 140 patients (recent AMI, TTS, or non-metastatic BC) and 140 healthy controls. To date, 19 AMI, 22 TTS, 27 BC patients, and 41 healthy subjects have been enrolled.
This presentation summarises enrolment and assessment tools, outlines the ontopsychological STP approach, and describes strategies to strengthen patient alliance throughout the study. A focus on the preliminary data analysis of the study is shown.